BA/BE studies of Biologics and Biosimilars

 A biosimilar is a biologic therapeutic item which is duplicate of a unique item that is produced by an alternate organization. Biosimilars are authoritatively sanction forms of unique "discoverer" items, and can be produced when the first item's patent terminates. Reference to the pioneer item is a fundamental part of the approbation.

 

  • Bioanalytical Approaches
  • Cancer therapeutics
  • Cardiovascular therapeutics
  • Diabetes therapeutics
  • Adverse drug reactions with pharmaceutical products

Related Conference of BA/BE studies of Biologics and Biosimilars

July 14-15, 2025

15th World Glycobiology Congress

Berlin, Germany
July 17-18, 2025

16th International Conference on Biofuels and Bioenergy

Amsterdam, Netherlands
September 08-09, 2025

23rd International Conference on Structural Biology

Frankfurt, Germany

BA/BE studies of Biologics and Biosimilars Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in